Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

Red light therapy could protect football players from brain damage, a new study suggests. Treatment reduced inflammation in ...

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have ...

This scan of a mouse brain shows blood vessels (red), brain cells (green), and amyloid plaques (blue). A new gene therapy treatment developed by UC San Diego works by reprogramming the behavior of ...

Alzheimer’s disease and other forms of dementia are medical conditions that target areas of the brain that control memory and behavior. While no singular cure has been established, therapeutic ...

Researchers from Drexel University’s College of Arts and Sciences and College of Medicine have found a potential new therapeutic target for Alzheimer’s disease. Expanding on their previous research on ...

Research led by Samsung Medical Center finds breast cancer survivors exhibit an 8% lower risk of Alzheimer's dementia (AD) compared with cancer-free individuals, with radiation therapy potentially ...

Anyone who’s ever gone through menopause knows the unpleasantness of the unrelenting hot flashes, brain fog, and other symptoms that crop up. Hormone therapy (HT) was, when it was first introduced in ...